Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-10-27

Clinical Trial Update: Efficacy of Intraoperative Injections on Postoperative Pain Control During Total Hip Replacement [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating intraoperative injections for postoperative pain control during total hip replacement has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rush University Medical Center | Conditions: Osteoarthritis, Degenerative Joint Disease | Phase 4 | Status: WITHDRAWN